Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block vs PCA for Recovery After Elective Cesarean Section
NCT06155968Completed
- Sponsor
- Ain Shams University
- Start
- Dec 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Obstetric Quality of Recovery-10 score. Started Dec 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06155968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06155968.